Barclays’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.06M Buy
224,404
+56,311
+33% +$266K ﹤0.01% 2628
2025
Q1
$771K Sell
168,093
-10,275
-6% -$47.1K ﹤0.01% 2596
2024
Q4
$854K Buy
178,368
+24,071
+16% +$115K ﹤0.01% 2723
2024
Q3
$722K Buy
154,297
+86,677
+128% +$406K ﹤0.01% 2799
2024
Q2
$382K Sell
67,620
-58,056
-46% -$328K ﹤0.01% 2692
2024
Q1
$516K Sell
125,676
-45,962
-27% -$189K ﹤0.01% 2815
2023
Q4
$725K Buy
171,638
+43,308
+34% +$183K ﹤0.01% 2802
2023
Q3
$554K Buy
128,330
+3,265
+3% +$14.1K ﹤0.01% 2482
2023
Q2
$824K Buy
125,065
+24,771
+25% +$163K ﹤0.01% 2276
2023
Q1
$682K Buy
100,294
+3,550
+4% +$24.1K ﹤0.01% 2416
2022
Q4
$716K Sell
96,744
-2,558
-3% -$18.9K ﹤0.01% 2359
2022
Q3
$981K Buy
99,302
+81,044
+444% +$801K ﹤0.01% 2146
2022
Q2
$199K Sell
18,258
-26,511
-59% -$289K ﹤0.01% 3125
2022
Q1
$507K Sell
44,769
-26,872
-38% -$304K ﹤0.01% 2800
2021
Q4
$1.12M Buy
71,641
+14,839
+26% +$233K ﹤0.01% 2130
2021
Q3
$974K Buy
56,802
+22,912
+68% +$393K ﹤0.01% 2267
2021
Q2
$729K Sell
33,890
-63,808
-65% -$1.37M ﹤0.01% 2281
2021
Q1
$1.47M Buy
97,698
+15,309
+19% +$230K ﹤0.01% 2083
2020
Q4
$1.08M Sell
82,389
-24,920
-23% -$328K ﹤0.01% 1927
2020
Q3
$1.04M Buy
107,309
+10,270
+11% +$99.1K ﹤0.01% 1903
2020
Q2
$1.11M Buy
97,039
+23,690
+32% +$271K ﹤0.01% 1859
2020
Q1
$760K Sell
73,349
-16,442
-18% -$170K ﹤0.01% 1902
2019
Q4
$1.47M Buy
89,791
+14,215
+19% +$233K ﹤0.01% 2063
2019
Q3
$1M Sell
75,576
-15,041
-17% -$200K ﹤0.01% 2256
2019
Q2
$1.28M Buy
90,617
+23,128
+34% +$326K ﹤0.01% 2163
2019
Q1
$1.24M Buy
67,489
+43,754
+184% +$806K ﹤0.01% 1980
2018
Q4
$620K Sell
23,735
-41,497
-64% -$1.08M ﹤0.01% 2137
2018
Q3
$1.5M Buy
65,232
+58,631
+888% +$1.35M ﹤0.01% 2000
2018
Q2
$126K Sell
6,601
-18,147
-73% -$346K ﹤0.01% 2969
2018
Q1
$417K Buy
24,748
+11,900
+93% +$201K ﹤0.01% 2409
2017
Q4
$195K Sell
12,848
-36,940
-74% -$561K ﹤0.01% 2664
2017
Q3
$891K Buy
49,788
+30,366
+156% +$543K ﹤0.01% 1647
2017
Q2
$318K Sell
19,422
-20,507
-51% -$336K ﹤0.01% 2167
2017
Q1
$559K Buy
39,929
+23,135
+138% +$324K ﹤0.01% 1891
2016
Q4
$267K Sell
16,794
-7,264
-30% -$115K ﹤0.01% 2158
2016
Q3
$401K Buy
24,058
+15,599
+184% +$260K ﹤0.01% 1829
2016
Q2
$95K Buy
8,459
+3,972
+89% +$44.6K ﹤0.01% 2359
2016
Q1
$36K Sell
4,487
-4,901
-52% -$39.3K ﹤0.01% 2634
2015
Q4
$84K Sell
9,388
-16,283
-63% -$146K ﹤0.01% 2358
2015
Q3
$282K Sell
25,671
-97
-0.4% -$1.07K ﹤0.01% 1977
2015
Q2
$310K Buy
25,768
+8,616
+50% +$104K ﹤0.01% 1932
2015
Q1
$154K Sell
17,152
-219,000
-93% -$1.97M ﹤0.01% 2358
2014
Q4
$3.31M Buy
236,152
+234,002
+10,884% +$3.28M ﹤0.01% 1100
2014
Q3
$23K Sell
2,150
-30,707
-93% -$328K ﹤0.01% 3357
2014
Q2
$526K Buy
32,857
+4,088
+14% +$65.4K ﹤0.01% 1982
2014
Q1
$461K Sell
28,769
-299,569
-91% -$4.8M ﹤0.01% 2026
2013
Q4
$3.94M Buy
328,338
+284,142
+643% +$3.41M ﹤0.01% 1091
2013
Q3
$442K Buy
44,196
+34,767
+369% +$348K ﹤0.01% 2183
2013
Q2
$76K Buy
+9,429
New +$76K ﹤0.01% 3171